<DOC>
	<DOCNO>NCT02660983</DOCNO>
	<brief_summary>The primary objective confirm donepezil hydrochloride superior efficacy improve cognitive function , measure Alzheimer 's Disease Assessment Scale-Cognitive subscale ( ADAS-cog ) , demonstrate donepezil hydrochloride superior efficacy improve global function , measure Clinician 's Interview-Based Impression Change-plus Caregiver Input ( CIBIC-plus ) , compare placebo patient dementia associate cerebrovascular disease ( VaD )</brief_summary>
	<brief_title>A Study Donepezil Hydrochloride Patients With Dementia Associated With Cerebrovascular Disease</brief_title>
	<detailed_description>This multi-center , randomize , double-blind , placebo-controlled , parallel-group study open-label extension . The study consist 3 phase ; screen phase ( 1 4 week ) , double-blind phase ( 24 week ) , Open-label extension phase ( 24 week ) .</detailed_description>
	<mesh_term>Dementia</mesh_term>
	<mesh_term>Cerebrovascular Disorders</mesh_term>
	<mesh_term>Donepezil</mesh_term>
	<criteria>Patients meet follow criterion eligible inclusion study : 1 . Male female , age ≥ 40 year time inform consent . 2 . Possible probable dementia associate cerebrovascular disease define National Institute Neurological Disorders Stroke ( NINDS ) Association Internationale pour la Recherche et l'Enseignement en Neurosciences ( AIREN ) criterion ( NINDSAIREN Criteria ) dementia great 3 month duration . 3 . Radiological evidence cerebrovascular disease . 4 . MiniMental Status Examination ( MMSE ) score ≥ 10 ≤ 24 . 5 . Clinical Dementia Rating ( CDR ) ≥ 1 . 6 . Outpatients physically healthy , ambulatory ambulatoryaided ( i.e. , walker , cane wheelchair ) . 7 . Written informed consent ( IC ) obtain patient ( possible ) patient 's legal guardian prior expose studyrelated procedure . The caregiver must separately provide IC his/her participation study . 8 . Patients caregiver submit write consent cooperate study , regular contact patient ( i.e. , average ≥ 4 hours/day ≥ 3 days/week ) , provide patient ' information necessary study , ensure regular administration assign donepezil , well concomitant therapy , correct dose , escort patient require visit study institution . 9 . Comorbid medical condition clinically stable prior Baseline , unless otherwise specify . Exclusion Criteria Patients meet follow criterion exclude : 1 . Antidementia drug therapy ( cholinesterase inhibitor memantine ) within 12 week prior Screening . 2 . Clinical and/or radiological evidence serious degenerative neurological disorder neuropsychiatric disorder . 3 . Known human immunodeficiency virus disease , neurosyphilis , history significant head trauma follow persistent neurological deficit know structural brain abnormality . 4 . Hypothyroidism Screening . 5 . Vitamin B12 folate deficiency Screening . 6 . Evidence new transient ischemic attack ( TIA ) stroke occurs within 12 week prior Screening , even symptom minor require hospitalization , exclude . 7 . Supine diastolic blood pressure ≥ 95 mmHg . 8 . Complication sick sinus syndrome , abnormal auricular atrioventricular ( AV ) junction conduction ( AV block , ≥ II ventricular block , etc . ) , prolong QT/QTc interval ( &gt; 450 m ) demonstrate repeat electrocardiogram ( ECG ) . 9 . A history lifethreatening arrhythmia . 10 . A history malignant neoplasm treat within 5 year prior study entry , current evidence malignant neoplasm , recurrent , metastatic disease . 11 . A known suspected history drug alcohol dependency abuse . 12 . Abnormal clinical laboratory value judge clinically significant investigator . 13 . Patients swallow difficulty swallow whole tablet , tablet break crush . 14 . Known plan elective surgery would require general anesthesia administration neuromuscular block agent . 15 . Pregnant woman , lactate woman , woman childbearing potential n't agree practice effective contraception throughout entire study period 30 day donepezil discontinuation , n't negative serum âHuman chorionic gonadotropin ( HCG ) test result negative urine pregnancy test result .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>